⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5493121 | 0.81 | PDE4D (0.40) | — | |
| SCHEMBL5487522 | 0.77 | PDE4D (0.39) | — | |
| SCHEMBL23069137 | 0.76 | HTR1B (0.37) | — | |
| SCHEMBL987091 | 0.76 | MEN1 (0.49) | — | |
| SCHEMBL70197 | 0.74 | LMNA (0.35) | — | |
| SCHEMBL1740905 | 0.70 | HTR1B (0.48) | — | |
| SCHEMBL23069122 | 0.70 | SLC6A4 (0.36) | — | |
| SCHEMBL15902430 | 0.69 | TAAR1 (0.57) | — | |
| SCHEMBL11693561 | 0.69 | PDE4D (0.40) | — | |
| SCHEMBL3526218 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7901949-B2 | Assay | ALERE SWITZERLAND GMBH (CH) | 2011-03-08 | — | — | US | claimed |
| EP-1701949-B1 | ASSAY FOR ENTACTOGENS | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2018-04-18 | — | — | EP | disclosed |
| EP-2382458-B1 | A CONDUCTIVITY MEASUREMENT CELL | SPD SWISS PREC DIAGNOSTICS GMBH (CH) | 2018-02-21 | — | — | EP | disclosed |
| US-9689821-B2 | Conductivity measurement cell | SPD SWISS PRECISION DIAGNOSTICS GMBH (CH) | 2017-06-27 | — | — | US | disclosed |
| US-9151749-B2 | Assay device comprising bubble-forming means | ALERE SWITZERLAND GMBH (CH) | 2015-10-06 | — | — | US | disclosed |
| EP-2269067-B1 | ASSAY DEVICE COMPRISING BUBBLE-FORMING MEANS | SPD SWISS PREC DIAGNOSTICS GMBH (CH) | 2015-02-25 | — | — | EP | disclosed |
| EP-1828106-B1 | METHAMPHETAMINE DERIVATIVES AND CONJUGATES FOR IMMUNOASSAY | ROCHE DIAGNOSTICS GMBH (DE) | 2012-10-31 | — | — | EP | disclosed |
| EP-2382458-A2 | A CONDUCTIVITY MEASUREMENT CELL | SPD Swiss Precision Diagnostics Gmbh (CH) | 2011-11-02 | — | — | EP | disclosed |
| US-20110223690-A1 | ASSAY | RAJ BALBIR | 2011-09-15 | — | — | US | disclosed |
| EP-2269067-A1 | ASSAY DEVICE COMPRISING BUBBLE-FORMING MEANS | SPD Swiss Precision Diagnostics Gmbh (CH) | 2011-01-05 | — | — | EP | disclosed |
| US-7101980-B2 | Derivatives, conjugates, and antibodies for detecting ecstasy-class analytes | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2006-09-05 | — | — | US | disclosed |
| US-20060134711-A1 | Methamphetamine derivatives and conjugates for immunoassay | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2006-06-22 | — | — | US | disclosed |
| WO-2006063829-A2 | METHAMPHETAMINE DERIVATIVES AND CONJUGATES FOR IMMUNOASSAY | ROCHE DIAGNOSTICS GMBH (DE) | 2006-06-22 | — | — | WO | disclosed |
| WO-2005059547-A2 | ASSAY | INVERNESS MEDICAL SWITZERLAND GMBH (CH) | 2005-06-30 | — | — | WO | disclosed |
| EP-1498428-A1 | Antibodies for detecting ecstasy-class analytes | Roche Diagnostics GmbH (DE) | 2005-01-19 | — | — | EP | disclosed |
| US-20040077021-A1 | Derivatives, conjugates, and antibodies for detecting ecstasy-class analytes | ROCHE DIAGNOSTICS CORPORATION | 2004-04-22 | — | — | US | disclosed |
| US-20030175995-A1 | Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2003-09-18 | — | — | US | disclosed |
| US-20030170917-A1 | Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes | ROCHE DIAGNOSTICS CORPORATION | 2003-09-11 | — | — | US | disclosed |
| EP-1340981-A2 | Antibodies for detecting amphetamine derivatives | Roche Diagnostics GmbH (DE) | 2003-09-03 | — | — | EP | disclosed |
| EP-1340980-A1 | Derivatives of amphetamine, antibodies against said derivatives, reagent kits, methods of producing said antibodies, and methods of detecting said derivatives | Roche Diagnostics GmbH (DE) | 2003-09-03 | — | — | EP | disclosed |